Familial dysautonomia is a progressive disorder in which there is a defect of the autonomic and sensory nervous systems. Clinical signs and symptoms present from birth and affect the functions of most body systems. These include the cardiovascular, gastrointestinal, neurological, renal and other systems.
If you have just received a diagnosis there is help and support available - please see ‘Further information and support’ below for links to valuable resources. It is also important to note that not every person with this condition experiences all the symptoms described and it is worth talking to your doctor or other relevant healthcare specialists to discuss you or your family member’s individual case.
Familial Dysautonomia is an autosomal recessiveRecessive disorders require both parents to carry a specific disorder-related mutation and pass it on to their child for the disorder to be inherited condition.
Symptoms and severity vary across individuals, however some common signs and symptoms include:
Intelligence is usually normal despite delays in certain developmental milestones such as walking or speech.
Please click on the titles to open and close the following information sections.
The disorder is caused by changes in the IKBKAP gene resulting in decreased production of a vital protein called IKAP. This protein is thought to have a role in the growth, development and functioning of the sensory and autonomic nervous systems.
Although no cure exists currently, a number of symptomatic therapies and surgical interventions can help to control the disorder signs and symptoms. In addition, paramedical treatment can be used to promote muscle strength and speech.
Symptoms progress with age and typically affect lifespan. However, as treatment is better understood, people with familial dysautonomia are experiencing an increased life expectancy and a better quality of life.
The disorder can be diagnosed clinically by a doctor familiar with the symptoms and by using a histamine test. The diagnosis can be confirmed or ruled out through genetic testing that involves a simple blood test.
Genetic analysis has identified four mutations for familial dysautonomia, and the major one accounts for over 99% of cases of the disorder in people of Ashkenazi Jewish ancestry. Both carrier testing and prenatal diagnosis are possible for this disorder.
Please refer to the testing section for more details.
Formerly known as DSGB. The only UK based charity dedicated to alleviating the suffering from FD. It helps provide specialized equipment, medication, support and respite for FD patients and families; facilitates access to international FD specialists and expertise; raises public awareness of FD and promotes screening for the disorder.
This USA based charity supports medical treatment, research, public awareness and social services for the benefit of people affected by FD. It has established the world’s only two FD treatment centers and is the largest single source of funding for research and treatment specifically for the benefit of people with FD.
An international group on Facebook for people with Familial Dysautonomia.
Click on the ‘Jane’s Story’ link above to see a short video of Jane Pearl sharing her family’s personal story of having a child affected by Familial Dysautonomia.
To find out more about general resources relevant to Jewish genetic disorders, please visit our resources and support section.